
January 13, 2026
The Pharmaceutical Research and Manufacturers of America (PhRMA) announced that hospital systems are marking up decades-old cancer drugs significantly above Medicare rates.
Read more →
November 26, 2025
Molly Jenkins, Senior Director of Public Affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA), said that the 340B program is increasing Medicare costs by blocking rebates and worsening taxpayer burdens — an issue garnering attention in Georgia.
Read more →
Sign-up for the Weekly Newsletter from Peach Tree Times.